Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
| ▸ | HTR1B | P28222 | 2/20 | 0.49 |
| ▸ | FDPS | P14324 | 3/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | HTR1D | P28221 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5353651 | 0.93 | KCNA3 (0.54) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL11154502 | 0.87 | PKM (0.59) | KCNA3PKMHTR1BFDPSLTA4H | |
| SCHEMBL5053396 | 0.83 | KCNA3 (0.52) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL21992785 | 0.79 | KCNA3 (0.73) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL26382700 | 0.79 | KCNA3 (0.73) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL17476344 | 0.79 | KCNA3 (0.59) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL17476340 | 0.79 | KCNA3 (0.59) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL5053425 | 0.79 | KCNA3 (0.59) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL17476331 | 0.79 | KCNA3 (0.59) | KCNA3HDAC1HDAC2PKMHDAC3 | |
| SCHEMBL11436349 | 0.79 | KCNA3 (0.59) | KCNA3HDAC1HDAC2PKMHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080275273-A1 | Method for Synthesizing Long-Chain Phosphonic Acid Derivatives and Thiol Derivatives | QIMONDA AG (DE) | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275273-A1 | Method for Synthesizing Long-Chain Phosphonic Acid Derivatives and Thiol Derivatives | TST, PORCN, PHOSPHO1 | KCNA3 4871/4885HDAC1 4220/4885HDAC2 4309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.